Editorial: Chronic Liver Disease: New Targets and New Mechanisms, Volume II

Front Mol Biosci. 2023 Jul 18:10:1237824. doi: 10.3389/fmolb.2023.1237824. eCollection 2023.

Authors

Sofia Jerez¹, Jinhang Gao², Enis Kostallari¹

Affiliations

¹ Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, China.
² Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China.

No abstract available

Keywords: NASH; hepatotoxicity; liver disease; metabolism; therapeutics.

Publication types

Editorial